Advertisement
Advertisement
GKOS
Glaukos Corporation
96.78
USDSponsored
-1.02
-1.04%
Mar 13, 12:11 UTC -4
Open
GKOS Earnings Reports
Positive Surprise Ratio
GKOS beat 28 of 41 last estimates.
68%
Next Report
Date of Next Report
Apr 28, 2026
Estimate for Q1 26 (Revenue/ EPS)
$139.72M
/-$0.26
Implied change from Q4 25 (Revenue/ EPS)
-2.38%
/-7.14%
Implied change from Q1 25 (Revenue/ EPS)
+30.99%
/+18.18%
Glaukos Corporation earnings per share and revenue
On Feb 17, 2026, GKOS reported earnings of -0.28 USD per share (EPS) for Q4 25, missing the estimate of -0.20 USD, resulting in a -39.93% surprise. Revenue reached 143.12 million, compared to an expected 139.12 million, with a 2.87% difference. The market reacted with a -5.26% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 15 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 139.72 million USD, implying an decrease of -7.14% EPS, and decrease of -2.38% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
$0.10
Surprise
+240.06%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Treace Medical Concepts, Inc. Common Stock
Report Date
Feb 27, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.15
Surprise
+1.96%
Nuwellis, Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$1.59
Actual
-$1.50
Surprise
+5.73%
FAQ
What were Glaukos Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Glaukos Corporation reported EPS of -$0.28, missing estimates by -39.93%, and revenue of $143.12M, 2.87% above expectations.
How did the market react to Glaukos Corporation's Q4 2025 earnings?
The stock price moved down -5.26%, changed from $110.23 before the earnings release to $104.43 the day after.
When is Glaukos Corporation expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for Glaukos Corporation's next earnings report?
Based on 15
analysts, Glaukos Corporation is expected to report EPS of -$0.26 and revenue of $139.72M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement